Xinhua Liu

22PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsOrganic chemical synthesisBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 13, 2026
Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.

|Jul 28, 2026
Discovery of a potent dual-target CDK8 and cyclin C PROTAC degrader for the treatment of colorectal cancer.

|Apr 03, 2026
Discovery and Evaluation of a PROTAC Degrader Targeting SAMHD1 for the Treatment of Pulmonary Fibrosis.

Xing Chen, Feilong Zhou, Qiansong Chen

|Jun 18, 2025
Enantioselective Synthesis of Chiral Triarylmethanes via Cu-Catalyzed Desymmetric Acyloxylation of Cyclic Non-coordinating Diaryliodoniums.

Jinlong Wang, Chengfei Fu, Xing Chen

|May 31, 2025
Discovery of Novel Potent Molecule for Treating Cisplatin-Induced Acute Kidney Injury Driven by Phenotypic Screening.

Yan Lou, Feilong Zhou, Daxing Shi

|Mar 28, 2025
Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases.

Duo Ma, Xianan Liu, Xingxing Zhang

Pageof 4

Frequent Collaborators

4 joint publications

Xing Chen

2 joint publications

Yazhou Lou

2 joint publications

Xiaodong Ma

2 joint publications

Yang Wang